Balyasny Asset Management »

Cytokinetics shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Cytokinetics shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $45M 34M 1.31
2024-03-31 $61M 39M 1.59
2023-12-31 $37M 21M 1.76

More positions owned by Balyasny Asset Management

Ishares Tr Russell 2000 Etf (IWM)
Apple Call Option (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Select Sector Spdr Tr Financial (XLF)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Core S&p Mcp Etf (IJH)
Vanguard Index Fds Total Stk Mkt (VTI)
Select Sector Spdr Tr Sbi Cons Discr (XLY)
Mastercard Incorporated Cl A Call Option (MA)
Hess Call Option (HES)
Lockheed Martin Corporation Call Option (LMT)
Endeavor Group Hldgs Cl A Com Put Option (EDR)

View all positions for Balyasny Asset Management

Top funds holding Cytokinetics

Wolverine Asset Management
Balyasny Asset Management
Lazard Asset Management
Point72 Asset Management
D. E. Shaw & Co
Readystate Asset Management
Aequim Alternative Investments
Polygon Management
State Street Corporation
DeepCurrents Investment Group
Bank of America Corporation
Morgan Stanley
Schroder Investment Management Group
BlackRock
BlackRock

View all funds holding Cytokinetics